News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novartis International AG (NVS) Painkiller Prexige Gets "Not Approvable" Letter in U.S.


9/27/2007 6:30:17 AM

ZURICH, Sept 27 (Reuters) - U.S. regulators have rejected Novartis AG's (NOVN.VX: Quote, Profile, Research) Prexige painkiller, a move that had been expected after Australia withdrew the drug on concerns over liver side-effects.

Read at Reuters
Read at Market Watch
Read at AP

comments powered by Disqus
Reuters
Market Watch
AP
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES